Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1981 1
1983 1
1985 1
1986 1
1987 2
1988 4
1989 3
1990 1
1991 9
1992 1
1993 5
1994 11
1995 9
1996 15
1997 10
1998 14
1999 12
2000 11
2001 13
2002 10
2003 17
2004 31
2005 32
2006 29
2007 38
2008 58
2009 45
2010 69
2011 67
2012 88
2013 80
2014 90
2015 138
2016 141
2017 184
2018 202
2019 223
2020 287
2021 186
Text availability
Article attribute
Article type
Publication date

Search Results

1,945 results
Results by year
Filters applied: . Clear all
Page 1
Epigenetic silencing of SALL2 confers tamoxifen resistance in breast cancer.
Ye L, Lin C, Wang X, Li Q, Li Y, Wang M, Zhao Z, Wu X, Shi D, Xiao Y, Ren L, Jian Y, Yang M, Ou R, Deng G, Ouyang Y, Chen X, Li J, Song L. Ye L, et al. Among authors: deng g. EMBO Mol Med. 2019 Dec;11(12):e10638. doi: 10.15252/emmm.201910638. Epub 2019 Oct 28. EMBO Mol Med. 2019. PMID: 31657150 Free PMC article.
Beclin 2 negatively regulates innate immune signaling and tumor development.
Zhu M, Deng G, Tan P, Xing C, Guan C, Jiang C, Zhang Y, Ning B, Li C, Yin B, Chen K, Zhao Y, Wang HY, Levine B, Nie G, Wang RF. Zhu M, et al. Among authors: deng g. J Clin Invest. 2020 Oct 1;130(10):5349-5369. doi: 10.1172/JCI133283. J Clin Invest. 2020. PMID: 32865519 Free PMC article.
1,945 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page